Aging Androgens/metabolism Anti-Inflammatory Agents Humans Inflammation Male *Prostatic Hyperplasia benign prostatic hyperplasia disease progression pathogenesis commercial or financial relationships that could be construed as a potential conflict of interest.

Benign prostatic hyperplasia Bipolar transurethral resection of the prostate Laser enucleation Meta-analysis Thulium laser enucleation of the prostate

Botulinum toxin benign prostatic hyperplasia Meta-analysis

Meta-Analysis as Topic Prevalence Risk Factors Prostatic Hyperplasia

Humans Male Network Meta-Analysis *Prostatic Hyperplasia/surgery Quality of Life Randomized Controlled Trials as Topic *Transurethral Resection of Prostate Treatment Outcome *benign prostatic hyperplasia *network meta-analysis *prostate volume *surgical treatment conflicts of interest with respect to the research authorship and/or publication of this article.

Anticoagulant therapy benign Prostatic Hyperplasia

Prostatic arterial embolization transurethral resection of the prostate benign prostatic hyperplasia meta-analysis

Surgical Treatments Benign Prostatic Hyperplasia Systematic Review Network Meta-Analysis

Anticoagulants Humans Male Platelet Aggregation Inhibitors Postoperative Hemorrhage/chemically induced Prostatic Hyperplasia *Transurethral Resection of Prostate

Benign prostatic hyperplasia Transurethral split of prostate Meta-analysis

Humans Male Outcome Assessment Health Care Prostatic Hyperplasia *Transurethral Resection of Prostate/statistics & numerical data Treatment Outcome

B-TURP HoLEP benign prostatic hyperplasia Meta-analysis

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects

Bladder-sparing strategy Clinical complete response Localized muscle-invasive bladder cancer Neoadjuvant Systemic treatment

非肌层浸润性膀胱癌 复发因素 Meta分析 地域差异

非肌层浸润性膀胱癌 热疗 膀胱内热灌注化疗 meta分析 经尿道膀胱肿瘤切除术

Data Systems Humans Magnetic Resonance Imaging/methods *Multiparametric Magnetic Resonance Imaging Reproducibility of Results Urinary Bladder/diagnostic imaging/pathology *Urinary Bladder Neoplasms/diagnostic imaging/surgery Bladder cancer Bladder cancer staging Multiparametric magnetic resonance imaging Muscle-invasive bladder cancer conflict of interest to disclose.

Catheterization time Conventional transurethral resection Cáncer vesical primario no músculo-infltrante Duración de la estancia hospitalaria En-bloc transurethral resection Length of hospital stay Primary non-muscle invasive bladder cancer Recurrence Recurrencia Resección transuretral convencional Resección transuretral en bloque Tiempo de sondaje

Humans Biomarkers Tumor *Carcinoma in Situ/diagnosis *Carcinoma Transitional Cell/pathology Hyaluronan Receptors/metabolism Keratin-20/analysis/metabolism Ki-67 Antigen/metabolism Tumor Suppressor Protein p53/analysis/metabolism Urinary Bladder *Urinary Bladder Neoplasms/pathology Urothelium/chemistry/metabolism/pathology Bladder carcinoma Carcinoma in situ Carcinoma vesical Displasia Dysplasia Immunomarkes Inmunomarcadores

Antineoplastic Agents/*therapeutic use Biomarkers Tumor/*blood Humans Male Neoadjuvant Therapy/*methods Prognosis Urinary Bladder Neoplasms/blood/drug therapy/*pathology Biomarkers Bladder cancer Nac Neoadjuvant chemotherapy Systematic review Ucb